Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse

• Status: Completed
• Trial end date: 2012-06-01

Summary

This is a single-centre, open-label prospective randomized pharmacodynamic investigation of 2 antiplatelet regimens in patients undergoing coronary intervention for ST segment elevation myocardial infarction(STEMI):

1. Tirofiban bolus only or bolus followed by 2 hour infusion on top of 600 mg clopidogrel or 60 mg prasugrel.

2. Prasugrel given at 60 mg.

• Phase: Phase 3

Details

• Lead Sponsor: Università degli Studi di Ferrara
• Treatments: Prasugrel Hydrochloride; Tirofiban